![Robert Niecestro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Niecestro
Director/Board Member at
Aspargo Laboratories, Inc.
Profile
Robert Niecestro was the founder of TG Therapeutics, Inc. (2011, Executive Vice President-Clinical & Regulatory) and Axsome Therapeutics, Inc. (2012, Vice President-Clinical & Regulatory).
Current jobs include Managing Director at AccelaPHARM LLC and Independent Director at Aspargo Labs, Inc. Former jobs include Senior Director-Clinical Development at Eisai, Inc., Director-Clinical Operations at Organon USA, Inc., Vice President-Clinical & Regulatory Affairs at Keryx Biopharmaceuticals, Inc., Vice President-Clinical Development at Andrx Laboratories, Inc., and Head-Regulatory Affairs at Tharimmune, Inc. Education includes an undergraduate degree from the University of Illinois and a doctorate from The University of Chicago.
Robert Niecestro active positions
| Companies | Position | Start |
|---|---|---|
AccelaPHARM LLC | Corporate Officer/Principal | - |
Aspargo Laboratories, Inc.
 Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on commercializing oral spray formulation of sildenafil citrate | Director/Board Member | - |
Former positions of Robert Niecestro
| Companies | Position | End |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
| CANTON STRATEGIC HOLDINGS, INC. | General Counsel | - |
Organon USA, Inc. | Corporate Officer/Principal | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | - |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Corporate Officer/Principal | - |
Training of Robert Niecestro
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon USA, Inc. | |
Andrx Laboratories, Inc.
Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Health Technology |
Aspargo Laboratories, Inc.
Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on commercializing oral spray formulation of sildenafil citrate | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
AccelaPHARM LLC |
- Stock Market
- Insiders
- Robert Niecestro
